Green Fresh Biotechnology Company Limited

As of December 31, 2024, Green Fresh Biotechnology Company Limited carries a market capitalization of 620.63M, placing it among publicly traded companies globally. Its enterprise value stands at 1.10B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of December 31, 2024, Green Fresh Biotechnology Company Limited has 874.12M shares outstanding.

These figures are as of December 31, 2024.

As of December 31, 2024, Green Fresh Biotechnology Company Limited maintains a current ratio of 1.74, meaning it holds 1.7x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended December 31, 2024.

As of the close on October 23, 2026, Green Fresh Biotechnology Company Limited's stock has declined approximately 4.55% over the past 52 weeks. The 50-day moving average sits at 0.66, while the 200-day moving average is 0.66.

As of December 31, 2024, Green Fresh Biotechnology Company Limited holds 128.49M in cash and equivalents against 601.42M in total debt, resulting in a net debt position of 469.17M. Total book value stands at 893.80M, with working capital of 471.37M providing operational flexibility.